ROR1, an embryonic protein with an emerging role in cancer biology

Area of Science:

• Molecular biology
• Cancer research
• Developmental biology

Background:

• Receptor tyrosine kinase-like orphan receptor 1 (ROR1) is part of the ROR family, featuring specific extracellular and transmembrane domains, plus intracellular tyrosine kinase and serine/threonine-rich domains.
• RORs play roles in embryonic development and neurogenesis, with functions dependent on the kinase domain.
• ROR1 is increasingly recognized as a cancer marker, particularly in hematologic malignancies like CLL, and is implicated in the progression of various blood and solid tumors.

Purpose of the Study:

• To investigate the role of Receptor tyrosine kinase-like orphan receptor 1 (ROR1) in cancer progression.
• To highlight ROR1 as a potential therapeutic target in oncology.

Main Methods:

• Literature review of ROR1's functions and expression patterns.
• Analysis of ROR1's involvement in cellular processes like apoptosis, EGFR signaling, and epithelial-mesenchymal transition (EMT).

Main Results:

• ROR1 expression is generally absent in adult tissues but present in embryonic tissues.
• ROR1 has been shown to inhibit apoptosis, enhance EGFR signaling, and induce EMT, contributing to cancer progression.
• ROR1 is a validated marker for certain cancers, including chronic lymphocytic leukemia (CLL).

Conclusions:

• ROR1's expression profile, being restricted to embryonic tissues and absent in normal adult tissues, makes it an attractive and specific drug target for cancer therapy.
• Targeting ROR1 may offer a novel therapeutic strategy for various hematologic and solid malignancies.